A PHASE I/IB SINGLE ARM STUDY OF TWO FRACTION SBRT WITH DOMINANT LESION SIB FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER

Brief description of study

This study wants to find out if a new way of treating prostate cancer is safe and possible. They will use a special kind of radiation, SBRT (Stereotactic Body Radiation Therapy), given in only two doses (2 fractions), based on how the cancer looks on an MRI and how it's classified genetically. They will focus on men who are 18 or older and have prostate cancer that has been confirmed with a biopsy. The goal is to see if this treatment will work for them with minimal side effects.


Clinical Study Identifier: s22-01306
Principal Investigator: Jonathan W Lischalk.
Other Investigators: Maya Dimitrova, Victor Ricardo Adorno Febles, Anthony Corcoran, Aaron Edward Katz, Mary K O'Keeffe, Samir Taneja, Todd J Carpenter, Jonathan Haas, Angela Tong, Moses M Tam, William C Huang, Hank Ng, David R. Wise.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.